Clinical Trials
3 trialsNCT05588648 2025-04-10
Study to Assess Safety and Efficacy of Vactosertib in Adolescents and Adults With Recurrent, Refractory or Progressive Osteosarcoma
MedPacto, Inc.
Phase 1/2 Recruiting
NCT03724851 2025-03-25
Vactosertib in Combination with Pembrolizumab in Metastatic Colorectal or Gastric Cancer
MedPacto, Inc.
Phase 1/2 Completed
NCT03698825 2024-12-09
TEW-7197 with Paclitaxel for the Treatment of Metastatic Gastric Cancer
MedPacto, Inc.
Phase 1/2 Completed